Quality of Life in Normogonadotropic Anovulation

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

300 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-07-01

Study Completion Date

2024-12-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Among the causes of ovulation disorders (group II of anovulation according to the World Health Organization classification), the dominant one is polycystic ovary syndrome (PCOS), and the remaining cases are classified as Hypothalamic-Pituitary-Ovarian Axis Dysfunction (HPOD). The exact etiology of both entities is unknown. To diagnose PCOS, the Rotterdam criteria must be met and other conditions that may cause hyperandrogenism or ovulation disorders must be excluded. PCOS is more often accompanied by other endocrine and metabolic disorders, such as obesity, dyslipidemia, hyperandrogenism, insulin resistance, diabetes, hyperprolactinemia and thyroid diseases, as well as infertility due to ovulation defect. These conditions not only significantly reduce quality of life (QoL), but also lead to an increased risk of cardiovascular disease, metabolic syndrome, adverse obstetric outcomes and an increased risk of endometrial cancer, further impairing QoL.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Uterine and Endometrial Volume in PCOS and HPOD

NCT06211608

Anovulation Irregular Menses

COMPLETED

Subclinical Hypothyroidism and Normogonadotropic Anovulation

NCT05782725

Polycystic Ovary Syndrome Hypothalamic-Pituitary-Ovarian Axis Dysfunction (Disorder)

COMPLETED

Intrauterine Environment in Polycystic Ovary Syndrome (PCOS) Probands

NCT00364949

Polycystic Ovary Syndrome

COMPLETED

The Effect of Polycystic Ovary Syndrome Phenotypes on Quality of Life and Sexual Function

NCT06428786

Polycystic Ovary Depression Sexual Dysfunction

COMPLETED

Psychological Traits, Sexuality and Quality of Life in Patients With Polycystic Ovary Syndrome

NCT03306459

Polycystic Ovary Syndrome

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

A prospective questionnaire study will be conducted regarding the quality of life among women undergoing hormonal diagnostics due to anovulation. The study will include women aged 18-45 with ovulation disorders: PCOS (arm 1) and HPOD (arm 2). The quality of life will be assessed using the self-assessment method using the SF-36 questionnaire (Short Form Health Survey). The questionnaire is intended for a subjective assessment of health status. It consists of 11 questions containing 36 statements that allow you to determine eight quality of life indicators, i.e.: physical functioning, role limitations due to physical health, role limitations due to emotional problems, energy/fatigue, emotional well-being, social functioning, pain, general health, health change.

The percentage score on a scale of 0-100% in each of the 8 life domains will be compared between both arms of the study.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Anovulation Irregular Menses

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Arm 1

Polycystic Ovary Syndrome (PCOS)

36-Item Short Form Survey Instrument (SF-36)

Intervention Type OTHER

Answering 36 questions in a quality-of-life survey (RAND 36-Item Health Survey 1.0): https://www.rand.org/health-care/surveys\_tools/mos/36-item-short-form/survey-instrument.html

Arm 2

Hypothalamic-Pituitary-Ovarian Axis Dysfunction

36-Item Short Form Survey Instrument (SF-36)

Intervention Type OTHER

Answering 36 questions in a quality-of-life survey (RAND 36-Item Health Survey 1.0): https://www.rand.org/health-care/surveys\_tools/mos/36-item-short-form/survey-instrument.html

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

36-Item Short Form Survey Instrument (SF-36)

Answering 36 questions in a quality-of-life survey (RAND 36-Item Health Survey 1.0): https://www.rand.org/health-care/surveys\_tools/mos/36-item-short-form/survey-instrument.html

Intervention Type OTHER